branchenspezifische Dividenden Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Aktien
ROVI
ES0157261019
ROVI
Pharmazeutika
|
Schlusskurs
Wiener Boerse
21.08.2026
|
% 5 Tage | Veränd. 1. Jan. | ||
| 59.60 EUR | -1.57% |
|
+2.14% | -5.85% |
| 23.07. | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23.07. | Laboratorios Farmaceuticos Rovi, S.A. legt Ergebnisse für das Halbjahr bis zum 30. Juni 2026 vor | CI |
Hauptkonkurrenten
| Dividendenrendite (Y) | Dividendenrendite (Y+1) | KGV (Y) | Price to Book (Y) | EV / Sales (Y) | Marktkap. / EBITDA (Y) | Marktkap. / EBIT (Y) | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.55% | 0.61% | 35.55x | 22.67x | 12.84x | 26.06x | 27.6x | 1’109 Mrd. | ||
| 2.01% | 2.1% | 29.74x | - | - | - | - | 644 Mrd. | ||
| 2.62% | 2.75% | 33.42x | -366.75x | 7.74x | 16.11x | 16.72x | 463 Mrd. | ||
| 2.69% | 2.75% | 20.72x | 7.44x | 4.91x | 12.16x | 13.49x | 371 Mrd. | ||
| 2.76% | 2.88% | 22.47x | 6.32x | 5.78x | 14.33x | 15.29x | 301 Mrd. | ||
| 2.02% | 2.14% | 21.12x | 4.75x | 4.35x | 12.35x | 13.07x | 256 Mrd. | ||
| 2.33% | 2.46% | 27.43x | 20.73x | 7.09x | 12.59x | 16.27x | 234 Mrd. | ||
| 3.81% | 3.77% | 13.47x | 5.61x | 4.79x | 10.05x | 11.7x | 205 Mrd. | ||
| 2.3% | 2.37% | -43.83x | 9.76x | 6.34x | 24.76x | 60.63x | 178 Mrd. | ||
| 6.2% | 6.25% | 17.41x | 1.8x | 3.31x | 8.44x | 9.63x | 158 Mrd. | ||
| -.--% | -.--% | 31.86x | 6.04x | 9.32x | 21.07x | 21.98x | 137 Mrd. | ||
| 3.86% | 3.93% | 11.66x | 5.5x | 3.26x | 8.46x | 9.17x | 134 Mrd. | ||
| 5.47% | 5.78% | 12.36x | 1.26x | 2.2x | 7.1x | 7.9x | 109 Mrd. | ||
| 3.62% | 3.9% | 14.52x | 4.67x | 2.83x | 8.38x | 9.33x | 105 Mrd. | ||
| 1.92% | 2.19% | 23.04x | 5.2x | 7.76x | 14.72x | 15.45x | 73.59 Mrd. | ||
| 3.51% | 3.58% | 47.52x | 1.25x | 2.82x | 9.94x | 29.64x | 58.59 Mrd. | ||
| 0.32% | 1.09% | 20.79x | 1.7x | 1.7x | 8.04x | 13.57x | 55.78 Mrd. | ||
| 0.55% | 0.58% | 36.35x | 5.01x | 8.32x | 28.26x | 29.71x | 48.45 Mrd. | ||
| -.--% | -.--% | 49.38x | 4.95x | 3.3x | 12.16x | 13.76x | 42.89 Mrd. | ||
| Durchschnitt | 2.45% | 2.59% | 22.37x | -14.01x | 5.48x | 14.17x | 18.61x | 246.49 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 2.15% | 2.25% | 24.85x | -31.55x | 7.53x | 17.03x | 20.19x |
- Börse
- Aktien
- A0M0GQ Aktie
- ROVI Aktie
- Sektor Laboratorios Farmaceuticos Rovi, S.A.
- branchenspezifische Dividenden
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















